Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Venous Thrombosis

Free Subscription Articles published in Thromb Res Retrieve available abstracts of 208 articles: HTML format

Single Articles

June 2026
1. DALLA VESTRA M, Autiero G, Malerba SA, Grolla E, et al
   Letter to the editor regarding "Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: A systematic review and meta-analysis." by Nicoletto M et al.
   Thromb Res. 2026;263:109757.
   PubMed    
   
   
   
2. TAO Y, Meng X, Tian H, Li X, et al
   Short-term performance of bleeding risk scores in anticoagulated older patients with acute pulmonary embolism.
   Thromb Res. 2026;263:109744.
   PubMed     Abstract available
   
   
   
3. MARTENS ESL, Akerboom B, Baumgartner C, Brouwer RE, et al
   A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.
   Thromb Res. 2026;263:109745.
   PubMed     Abstract available
   
   
   
4. WEI Y, Li J, Jia Y, Liu B, et al
   Rivaroxaban for pediatric venous thromboembolism in routine clinical practice: Effectiveness and safety from a real-world cohort.
   Thromb Res. 2026;263:109730.
   PubMed     Abstract available
   
   
   May 2026
5. MILOVANOVIC N, Zivanic A, Jovanovic IV, Neskovic SA, et al
   Prolonged D-dimer elevation after COVID-19: diagnostic noise or residual risk in suspected pulmonary embolism?
   Thromb Res. 2026;262:109721.
   PubMed    
   
   
   
6. KHAN S, Jimenez Munarriz B, Hueniken K, Tianzhichao H, et al
   Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).
   Thromb Res. 2026;263:109717.
   PubMed    
   
   
   
7. TER HAAR SNM, Eikenboom JCJ, den Exter PL, van Meer OA, et al
   Evaluation of patient experiences with a structured home treatment pathway for pulmonary embolism using direct oral anticoagulants.
   Thromb Res. 2026;262:109713.
   PubMed     Abstract available
   
   
   
8. CHRISTODOULOU KC, Hobohm L, Mohr K, Farmakis IT, et al
   Temporal trends and risk factors of extracranial major bleeding in patients with acute pulmonary embolism.
   Thromb Res. 2026;262:109711.
   PubMed     Abstract available
   
   
   April 2026
9. PELLAND-MARCOTTE MC, Tran TH, Ethier C, Beaulieu C, et al
   Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia.
   Thromb Res. 2026;261:109691.
   PubMed     Abstract available
   
   
   
10. YAP ES, Braekkan SK, Lijfering WM, Rosendaal FR, et al
    C-reactive protein and risk of venous thromboembolism - results from the MEGA study.
    Thromb Res. 2026;261:109668.
    PubMed     Abstract available
    
    
    
11. SURANA A, Bhattacharya R, Saji E, Jacob J, et al
    Acute pulmonary embolism incidence and mortality during the COVID-19 pandemic: A national inpatient sample analysis 2017-2022.
    Thromb Res. 2026;261:109679.
    PubMed     Abstract available
    
    
    
12. NICOLETTO M, Maino A, Guarascio M, Cavalleri MA, et al
    Anticoagulation therapy vs clinical surveillance in isolated subsegmental pulmonary embolism: a systematic review and meta-analysis.
    Thromb Res. 2026;261:109669.
    PubMed     Abstract available
    
    
    March 2026
13. FUKSMAN A, Shliakhtsitsava K, Nguyen G, Umaretiya PJ, et al
    Patient-parent perspectives in designing pediatric venous thromboembolism research: A qualitative study.
    Thromb Res. 2026;260:109659.
    PubMed    
    
    
    
14. MITIC MM, Usjak D, Kovac M, Basaric D, et al
    Exploring genetic drivers of unexplained venous thromboembolism through whole-exome sequencing.
    Thromb Res. 2026;260:109653.
    PubMed     Abstract available
    
    
    
15. BAO W, Li Y, Ji H, Du Y, et al
    Changes in right ventricular function in patients with acute pulmonary thromboembolism as assessed by transthoracic echocardiography: A one-year follow-up study.
    Thromb Res. 2026;260:109634.
    PubMed    
    
    
    
16. EINARSSON ASKELI F, Andersen A, Glise Sandblad K, Martinell L, et al
    Reperfusion treatment strategies in acute pulmonary embolism: Study protocol for a multicenter prospective observational study in the Nordic countries (PE-NORDIC).
    Thromb Res. 2026;260:109635.
    PubMed     Abstract available
    
    
    February 2026
17. SATO T, Ogihara Y, Yamashita Y, Morimoto T, et al
    Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial.
    Thromb Res. 2026;259:109631.
    PubMed    
    
    
    
18. KENNY C, Curran F, Lennon O, O'Neill AM, et al
    Barriers and facilitators to healthy lifestyle behaviours for people living with post pulmonary embolism syndrome. A qualitative study exploring participants lived experiences.
    Thromb Res. 2026;259:109625.
    PubMed     Abstract available
    
    
    
19. NASEF Y, Brown A, Prashar S, Bundschu I, et al
    Evaluating clinical outcomes for very early versus late venous thromboembolism prophylaxis in patients with isolated severe spinal trauma.
    Thromb Res. 2026;259:109627.
    PubMed     Abstract available
    
    
    
20. SUN L, Wang J, Yan YD, Li LT, et al
    Evolving biomarkers and risk prediction models in colorectal cancer-associated venous thromboembolism.
    Thromb Res. 2026;259:109619.
    PubMed     Abstract available
    
    
    
21. ZUIN M, Chopard R, Becattini C, Drachman DE, et al
    Identifying the spectrum of clinical trajectories in intermediate-high risk pulmonary embolism: A clinical and research imperative.
    Thromb Res. 2026;259:109621.
    PubMed     Abstract available
    
    
    
22. BUIJS JT, van Es N, Englisch C, Anijs RJS, et al
    Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.
    Thromb Res. 2026;259:109612.
    PubMed     Abstract available
    
    
    
23. MARTIN KA, Hallgren E, Holmes CE, Barker J, et al
    Venous thromboembolism prevention in ambulatory oncology: A multi-method evaluation of the Vermont Model to inform adaptation to an oncology-delivered model.
    Thromb Res. 2026;259:109610.
    PubMed     Abstract available
    
    
    January 2026
24. HE R, Zhang X, Tang X, Shen Y, et al
    The distinct etiology and imaging features of pediatric pulmonary embolism: dominance of Mycoplasma pneumoniae-associated in-situ thrombosis and severity risk stratification.
    Thromb Res. 2026;259:109597.
    PubMed     Abstract available
    
    
    
25. FROST AC, Baris VK, Sainlaire M, Chen J, et al
    A model to guide successful living with venous thromboembolism (VTE): Recommendations derived from the qualitative phase of a study of diagnostic Delay of VTE (DOVE).
    Thromb Res. 2026;258:109585.
    PubMed     Abstract available
    
    
    
26. FAN D, Lanting V, Camilleri E, Bos MHA, et al
    Coagulation parameters in gastrointestinal cancer patients with venous thromboembolism.
    Thromb Res. 2026;258:109587.
    PubMed     Abstract available
    
    
    
27. PFEFERMAN M, Rashedi S, Pandey AK, Krishnathasan D, et al
    Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trial.
    Thromb Res. 2026;258:109588.
    PubMed    
    
    
    
28. ZHANG A, Li G, Wu X
    CARE-Net: Causal-aware risk embedding for venous thromboembolism prediction in orthopedic inpatients.
    Thromb Res. 2026;258:109571.
    PubMed     Abstract available
    
    
    November 2025
29. FUMAGALLI RM, von Stempel C, Pleming W, Klok FA, et al
    Comparative outcomes of ultrasound-assisted catheter-directed thrombolysis between patients with acute and acute-on-chronic pulmonary embolism.
    Thromb Res. 2025;257:109552.
    PubMed     Abstract available
    
    
    
30. RAAD MK, Prozora S, Faustino EVS
    Absolute time-dependent risk of hospital-acquired venous thromboembolism in children.
    Thromb Res. 2025;257:109553.
    PubMed     Abstract available
    
    
    
31. INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
    Psychometric properties of patient-related outcome measures used for patients surviving a pulmonary embolism: A systematic review.
    Thromb Res. 2025;257:109543.
    PubMed     Abstract available
    
    
    October 2025
32. SHEN BH, Shankar DA, Bosch NA, Walkey AJ, et al
    Contemporary reperfusion therapies in patients with intermediate- and high-risk pulmonary embolism.
    Thromb Res. 2025;256:109523.
    PubMed     Abstract available
    
    
    
33. HUGUENY J, de Ricolfis A, Johnson N, Chabbert-Buffet N, et al
    Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review.
    Thromb Res. 2025;256:109516.
    PubMed     Abstract available
    
    
    
34. LI HY, Wang HS, Wang J, Wang YH, et al
    Management of venous thromboembolism in stroke: A deep appraisal exposing discordance in guideline quality and recommendations.
    Thromb Res. 2025;256:109515.
    PubMed     Abstract available
    
    
    
35. CRICHI B, Delrue M, Alsuliman T, Le Jeune S, et al
    Reduced-dose versus full-dose apixaban for extended treatment of cancer-associated venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
    Thromb Res. 2025;256:109505.
    PubMed    
    
    
    
36. GE WJ, Zhu TF, Ge WJ, Zhu XY, et al
    Systematic review of a machine learning model for prediction of venous thromboembolism risk.
    Thromb Res. 2025;256:109507.
    PubMed     Abstract available
    
    
    
37. LI S, Wang M, Xu Y
    Predictors of pulmonary infarction in pediatric pulmonary embolism: A retrospective cohort study.
    Thromb Res. 2025;255:109502.
    PubMed     Abstract available
    
    
    
38. AVIEL G, Raccah-Hirsh B, Abu-Ghannam R, Oren N, et al
    Has systemic thrombolysis run its course? A systematic review and network meta-analysis of patients with intermediate- and high-risk pulmonary embolism.
    Thromb Res. 2025;255:109503.
    PubMed     Abstract available
    
    
    September 2025
39. KELLER K, Schmitt VH, Sivanathan V, Hahad O, et al
    Cystic fibrosis and its impact on prognosis in pulmonary embolism.
    Thromb Res. 2025;255:109499.
    PubMed     Abstract available
    
    
    
40. PEREZ MARTIN A, Leger L, Chea M, Boudemaghe T, et al
    Seasonality and territorial gradient of pulmonary embolism in France: an 8-year retrospective nationwide analysis.
    Thromb Res. 2025;255:109492.
    PubMed     Abstract available
    
    
    
41. SORELLA S, Biglietto M, Zhdanovskaya N, Merli M, et al
    Full vs. low-dose of direct oral anticoagulants as extended secondary prophylaxis of venous thromboembolism in the splanchnic venous thrombosis.
    Thromb Res. 2025;255:109481.
    PubMed    
    
    
    
42. FAHEEM MSB, Fatima Y, Munir SU, Khabir M, et al
    Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999-2024: A population-based analysis using CDC WONDER Data.
    Thromb Res. 2025;255:109482.
    PubMed     Abstract available
    
    
    
43. CHAN A, Chrysafi P, Angelini D, Schaefer JK, et al
    An international survey of clinician recommendations for physical activity after venous thromboembolism.
    Thromb Res. 2025;255:109478.
    PubMed    
    
    
    
44. IBRAHIM A, Shalabi L, Zreigh S, Tawfik AM, et al
    Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data.
    Thromb Res. 2025;254:109476.
    PubMed     Abstract available
    
    
    August 2025
45. KADAKIA KT, Bikdeli B
    When clots go to court: Clinical insights from litigation for venous thromboembolism in orthopedic surgery.
    Thromb Res. 2025;254:109442.
    PubMed    
    
    
    
46. ARIF HA, Miner A, Moore ST, LeBrun G, et al
    Characteristics and outcomes of venous thromboembolism-related litigation in orthopaedic surgery.
    Thromb Res. 2025;254:109443.
    PubMed     Abstract available
    
    
    
47. STENGER WJE, den Uil CA, Rietdijk WJR, Al Amri I, et al
    Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial.
    Thromb Res. 2025;255:109420.
    PubMed     Abstract available
    
    
    July 2025
48. BOCCATONDA A, Simion C, Brighenti A, Serra C, et al
    Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6 months of therapy: A narrative review.
    Thromb Res. 2025;253:109403.
    PubMed     Abstract available
    
    
    
49. GONZALEZ-MENDOZA DE, Fernandez-Nogueira F, Uribe M, Chavez-Tapia NC, et al
    Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE).
    Thromb Res. 2025;253:109395.
    PubMed     Abstract available
    
    
    
50. WHITWORTH H, Wagner K, Zelinski A, DiCocco E, et al
    A novel Computable phENotype To Identify Pulmonary Embolism in chilDrEn: The CENTIPEDE Study.
    Thromb Res. 2025;253:109385.
    PubMed     Abstract available
    
    
    June 2025
51. JORGENSEN CT, Tavoly M, Pettersen HH, Fronaes S, et al
    Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry.
    Thromb Res. 2025;252:109386.
    PubMed     Abstract available
    
    
    
52. FREUND O, Pelcman D, Urtreger NO, Bar-Shai A, et al
    High rate of immediate and early post-traumatic venous thromboembolism in combat soldiers.
    Thromb Res. 2025;252:109382.
    PubMed     Abstract available
    
    
    
53. SOUZA MEM, Ferreira LGR, Silva NRO, Lopes LR, et al
    Thrombin generation assay in venous thromboembolism: A scoping review.
    Thromb Res. 2025;252:109384.
    PubMed     Abstract available
    
    
    
54. MENDOZA-ZAMBRANO E, Ballaz-Quincoces A, Lobo JL, Gomez-Cuervo C, et al
    Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts.
    Thromb Res. 2025;252:109379.
    PubMed    
    
    
    
55. ZUIN M, Piazza G, Rigatelli G, Bongarzoni A, et al
    Clinical phenotypes and risk of early hemodynamic deterioration in intermediate-high-risk patients with acute pulmonary embolism.
    Thromb Res. 2025;252:109380.
    PubMed     Abstract available
    
    
    
56. BORIS D, Tamara S, Jovan M, Sandra P, et al
    Comparing fibrinolytic strategies in intermediate-high-risk pulmonary embolism: Insights from a multicenter registry.
    Thromb Res. 2025;252:109372.
    PubMed    
    
    
    
57. RUEDA-CAMINO JA, Angelina-Garcia M, Trujillo-Luque D, Joya-Seijo MD, et al
    Sex-based differences in access to reperfusion therapies for pulmonary embolism in Spain during the 2016-2022 period.
    Thromb Res. 2025;252:109371.
    PubMed     Abstract available
    
    
    
58. HAUKELAND-PARKER S, Jervan O, Ghanima W, Spruit MA, et al
    The effect of exercise-based rehabilitation on objective physical activity levels in patients with persistent dyspnoea following pulmonary embolism.
    Thromb Res. 2025;252:109362.
    PubMed     Abstract available
    
    
    May 2025
59. BOUZID D, Rouzaud D, Rio J, Borie R, et al
    Performance of new 2023 ACR/EULAR antiphospholipid syndrome classification criteria in young patients admitted for pulmonary embolism.
    Thromb Res. 2025;252:109359.
    PubMed    
    
    
    
60. TEO TW, Tan SML, Chiang YY, Oh JR, et al
    Impact of mechanical pulmonary thrombectomy for intermediate-risk pulmonary embolism: Results from a prospective multicenter, multi-ethnic Asian registry.
    Thromb Res. 2025;251:109357.
    PubMed     Abstract available
    
    
    
61. GONG A, Wei X, Liu Y, Chen Z, et al
    Corrigendum to "SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons" [Thromb. Res. volume 250 (2025) 109334].
    Thromb Res. 2025;251:109350.
    PubMed    
    
    
    
62. LEINWEBER ME, Taher F, Assadian A, Hofmann A, et al
    Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023.
    Thromb Res. 2025;251:109337.
    PubMed     Abstract available
    
    
    
63. GONG A, Wei X, Liu Y, Chen Z, et al
    SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons.
    Thromb Res. 2025;250:109334.
    PubMed     Abstract available
    
    
    
64. GROAT D, Martin KA, Rosovsky RP, Sanfilippo KM, et al
    Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment.
    Thromb Res. 2025;250:109338.
    PubMed     Abstract available
    
    
    April 2025
65. BROWN C, Mallick R, Pecarskie A, Shaw JR, et al
    Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapy.
    Thromb Res. 2025;250:109335.
    PubMed     Abstract available
    
    
    
66. ZHANG RS, Yuriditsky E, Truong HP, Zhang P, et al
    Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio.
    Thromb Res. 2025;250:109323.
    PubMed     Abstract available
    
    
    March 2025
67. SQUIZZATO A, De Pascali F, Pengo V, Donadini MP, et al
    Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis.
    Thromb Res. 2025 Mar 29:109313. doi: 10.1016/j.thromres.2025.109313.
    PubMed    
    
    
    
68. KUMAR S, Razaqi N, Mehta R, Sah R, et al
    Comment on: "Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis".
    Thromb Res. 2025;249:109312.
    PubMed    
    
    
    
69. KUNO T, Koitabashi N, Yamashita Y, Morimoto T, et al
    Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2.
    Thromb Res. 2025;249:109311.
    PubMed    
    
    
    
70. ZHANG H, Lu X, Guo Z, Jiang X, et al
    Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism.
    Thromb Res. 2025;249:109310.
    PubMed     Abstract available
    
    
    
71. AMIRSARDARI Z, Khalili A, Sharafi M, Mehrizi R, et al
    Metabolomics profiling in venous thromboembolism and its chronic sequelae - A systematic review.
    Thromb Res. 2025;249:109309.
    PubMed     Abstract available
    
    
    
72. LIU K, Hu C, Zhou LY, Tang ZY, et al
    The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials.
    Thromb Res. 2025;249:109294.
    PubMed     Abstract available
    
    
    February 2025
73. GIERTZ M, Aarnivala H, Michelsen SW, Bjorklund C, et al
    Venous thromboembolism in children with Hodgkin lymphoma - A population-based study in Sweden, Finland, and Denmark.
    Thromb Res. 2025;248:109287.
    PubMed     Abstract available
    
    
    
74. WANG TF, Luo S, Gage BF, Schoen MW, et al
    Association between anticoagulant-related bleeding and mortality in patients with hematological malignancies and cancer-associated venous thromboembolism.
    Thromb Res. 2025;248:109284.
    PubMed     Abstract available
    
    
    
75. VOSTATEK R, Trappl M, Englisch C, Hohensinner P, et al
    Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer.
    Thromb Res. 2025;248:109285.
    PubMed     Abstract available
    
    
    January 2025
76. GHORBANZADEH A, Levin DL, Kuzo RS, McBane RD 2nd, et al
    Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli.
    Thromb Res. 2025;247:109275.
    PubMed    
    
    
    
77. SAAD M, Batool RM, Waqas SA, Sohail MU, et al
    Unveiling the trends: Growing cancer and venous thromboembolism mortality in older adults in the United States, 1999-2020.
    Thromb Res. 2025;247:109259.
    PubMed     Abstract available
    
    
    
78. SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
    Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism.
    Thromb Res. 2025;247:109274.
    PubMed     Abstract available
    
    
    
79. RASHEDI S, Bejjani A, Hunsaker AR, Aghayev A, et al
    Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports.
    Thromb Res. 2025;247:109271.
    PubMed     Abstract available
    
    
    
80. HASSAN E, Sutton D, Buka RJ, Lowe G, et al
    Disparities in menstrual bleeding management during acute venous thromboembolism treatment: A review of UK practice and a call for clinical studies.
    Thromb Res. 2025;247:109258.
    PubMed     Abstract available
    
    
    
81. CHARLES S, Fatrara T, Bouriche T, Bonifay A, et al
    Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis.
    Thromb Res. 2025;247:109256.
    PubMed     Abstract available
    
    
    December 2024
82. LIN J, Li W, Zhang X, Zhou K, et al
    Thromboembolic events associated with immune checkpoint inhibitors in cancer patients: A Bayesian network meta-analysis.
    Thromb Res. 2024;246:109243.
    PubMed     Abstract available
    
    
    
83. BOSCH FTM, Dijk F, Briede S, Groen JV, et al
    Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma.
    Thromb Res. 2024;246:109240.
    PubMed     Abstract available
    
    
    
84. LI Y, Xi L, Wang D, Fan G, et al
    Risk of bleeding in pulmonary embolism patients concomitant with COVID-19 undergoing extended anticoagulation: A multicenter cohort study.
    Thromb Res. 2024;246:109237.
    PubMed     Abstract available
    
    
    
85. KENNY C, Lennon O, Klok FA, Matthews J, et al
    Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis.
    Thromb Res. 2024;246:109242.
    PubMed     Abstract available
    
    
    
86. YANG D, Deng J, Huang S, He H, et al
    Clinical features, outcomes, and anticoagulant strategies in lung cancer-associated isolated distal deep vein thrombosis.
    Thromb Res. 2024;244:109193.
    PubMed     Abstract available
    
    
    November 2024
87. TANDON P, Thompson C, Li K, McLeod SL, et al
    Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism.
    Thromb Res. 2024;245:109234.
    PubMed    
    
    
    
88. DE PASCALI F, Filippova YA, Donadini MP, Pengo V, et al
    Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis.
    Thromb Res. 2024;245:109225.
    PubMed     Abstract available
    
    
    
89. GARCIA-GARCIA V, Barca-Hernando M, Lopez-Ruz S, Rosa-Linares C, et al
    Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study.
    Thromb Res. 2024;245:109228.
    PubMed     Abstract available
    
    
    
90. PRANDONI P, Bilora F, Pesavento R, Pedrajas JM, et al
    DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2024;245:109226.
    PubMed    
    
    
    
91. VANDENHAZEL HL, Wilson AS, Ye X, Vazquez SR, et al
    Direct oral anticoagulant prescribing trends for venous thromboembolism among adult patients with obesity at University of Utah Health.
    Thromb Res. 2024;245:109216.
    PubMed     Abstract available
    
    
    
92. AMSTER R, Watad A, Shani U, McGonagle D, et al
    Increased risk of pulmonary embolism in patients with dermatomyositis/polymyositis, a retrospective cohort study from Israel.
    Thromb Res. 2024;244:109203.
    PubMed     Abstract available
    
    
    October 2024
93. ZHENG X, Xu M, Zhang Z, Yang L, et al
    Microbial signatures in chronic thromboembolic pulmonary hypertension thrombi: Insights from metagenomic profiling of fresh and organized thrombi.
    Thromb Res. 2024;244:109204.
    PubMed     Abstract available
    
    
    
94. UNO H, Xiong H, Cronin C, Schrag D, et al
    Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial.
    Thromb Res. 2024;244:109184.
    PubMed     Abstract available
    
    
    
95. BRICENO W, Gonzalez S, Rodriguez C, Castillo A, et al
    Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study.
    Thromb Res. 2024;244:109179.
    PubMed    
    
    
    
96. YURIDITSKY E, Zhang RS, Zhang P, Horowitz JM, et al
    Inferior vena cava contrast reflux grade is associated with a reduced cardiac index in acute pulmonary embolism.
    Thromb Res. 2024;244:109177.
    PubMed     Abstract available
    
    
    September 2024
97. MCELROY S, Cramer E, Amos L
    COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics.
    Thromb Res. 2024;243:109169.
    PubMed     Abstract available
    
    
    
98. CHRISTODOULOU KC, Mohr K, Uphaus T, Jagersberg M, et al
    Evolving patterns of intracranial hemorrhage in advanced therapies in patients with acute pulmonary embolism.
    Thromb Res. 2024;243:109168.
    PubMed     Abstract available
    
    
    
99. MAESTRE A, Martin Del Pozo M, Moustafa F, Chopard R, et al
    Predicting intracranial bleeding during anticoagulation for venous thromboembolism within different time frames: Findings from the RIETE registry.
    Thromb Res. 2024;243:109153.
    PubMed     Abstract available
    
    
    
100. SYROWATKA A, Pullman A, Pajares E, White K, et al
     Accurately identifying incident cases of venous thromboembolism in the electronic health record: Performance of a novel phenotyping algorithm.
     Thromb Res. 2024;243:109143.
     PubMed     Abstract available
     
     
     
101. TIAN H, Zhang Y, Liu J, Yang Y, et al
     Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES.
     Thromb Res. 2024;243:109146.
     PubMed     Abstract available
     
     
     
102. FERREIRA BA, Danielian PLLB, Caetano GC, Ferreira CRL, et al
     Incidence of venous thromboembolism and adequacy of thromboprophylaxis in 2380 acutely-ill hospitalized patients: Results from the PROFMiG cohort study.
     Thromb Res. 2024;243:109145.
     PubMed     Abstract available
     
     
     
103. SMIT JM, Haaksma ME, Heldeweg MLA, Adamse DS, et al
     Incidence of catheter-related thrombosis and its association with outcome in critically ill patients: A prospective observational study.
     Thromb Res. 2024;241:109068.
     PubMed     Abstract available
     
     
     August 2024
104. BERGGREEN C, Schroder JH, Christensen T, Szejniuk WM, et al
     TO INFORM OR NOT TO INFORM about venous thromboembolisms - A qualitative study on communication between healthcare professionals and patients with lung cancer.
     Thromb Res. 2024;243:109132.
     PubMed     Abstract available
     
     
     
105. HANSEN AL, Hojen AA, Lindegaard SF, Grove EL, et al
     The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.
     Thromb Res. 2024;242:109133.
     PubMed     Abstract available
     
     
     
106. REYES GIL M, Pantanowitz J, Rashidi HH
     Venous thromboembolism in the era of machine learning and artificial intelligence in medicine.
     Thromb Res. 2024;242:109121.
     PubMed     Abstract available
     
     
     
107. CHIANG CH, Xu X, Song J, Xanthavanij N, et al
     The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer.
     Thromb Res. 2024;242:109119.
     PubMed    
     
     
     
108. DU Y, Yang A, Wang X
     Accuracy of transthoracic lung ultrasound for diagnosing pulmonary embolism: An updated systematic review and meta-analysis.
     Thromb Res. 2024;241:109112.
     PubMed     Abstract available
     
     
     July 2024
109. ZHU YF, Ma JH, Qian H, Shen NN, et al
     Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting.
     Thromb Res. 2024;241:109107.
     PubMed     Abstract available
     
     
     
110. CHRISTENSEN MA, Stubblefield WB, Wang G, Altheimer A, et al
     Derivation and external validation of a portable method to identify patients with pulmonary embolism from radiology reports: The READ-PE algorithm.
     Thromb Res. 2024;241:109105.
     PubMed     Abstract available
     
     
     
111. BEG KA, Chen S, Makoni M, Khan O, et al
     Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients.
     Thromb Res. 2024;241:109098.
     PubMed     Abstract available
     
     
     
112. SRIVASTAVA S, Kumari B, Garg I, Prince, et al
     Panel of genetic risk markers for prediction of susceptibility towards venous thromboembolism (VTE).
     Thromb Res. 2024;241:109104.
     PubMed    
     
     
     
113. VICTORRI-VIGNEAU C, Guerlais M, Jaulin E, Laforgue EJ, et al
     Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert.
     Thromb Res. 2024;241:109096.
     PubMed    
     
     
     
114. PEREZ-JACOISTE ASIN MA, Blanco Molina A, Gomez-Cuervo C, Diaz-Pedroche MDC, et al
     Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry.
     Thromb Res. 2024;241:109087.
     PubMed     Abstract available
     
     
     
115. LIPPI G, Mattiuzzi C
     Analysis of real-world data pulmonary embolism as the underlying cause of death during the COVID-19 pandemic.
     Thromb Res. 2024;241:109089.
     PubMed    
     
     
     June 2024
116. OVERVAD TF, Severinsen MT, Johnsen SP, Madsen SS, et al
     Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register.
     Thromb Res. 2024;241:109074.
     PubMed     Abstract available
     
     
     
117. KAPTEIN FHJ, Stoger JL, van Dam LF, Ninaber MK, et al
     Computed tomography diagnosis of pulmonary infarction in acute pulmonary embolism.
     Thromb Res. 2024;241:109071.
     PubMed     Abstract available
     
     
     
118. MA SG, Yang Y, Huang Y
     Venous thromboembolism risk assessment scale for prediction of venous thromboembolism in inpatients with cancer: A meta-analysis.
     Thromb Res. 2024;240:109058.
     PubMed     Abstract available
     
     
     May 2024
119. EMAD Y, Ragab Y, Farber HW, Erkan D, et al
     Pulmonary embolism versus pulmonary vasculitis in Hughes-Stovin syndrome: Characteristic computed tomography pulmonary angiographic findings and diagnostic and therapeutic implications. HSS International Study Group.
     Thromb Res. 2024;239:109040.
     PubMed     Abstract available
     
     
     
120. GIRARDI L, Ciuffini LA, Mai V, Santagata D, et al
     Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism.
     Thromb Res. 2024;239:109037.
     PubMed     Abstract available
     
     
     
121. IOURINETS J, Sawalski C, Desai P, Sutherland D, et al
     Prevalence and outcome of acute pulmonary embolism in hospitalized patients with a history of inflammatory bowel disease.
     Thromb Res. 2024;239:109035.
     PubMed    
     
     
     
122. WAN T, Garland SJ, Drury CT, Lambert J, et al
     Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients.
     Thromb Res. 2024;239:109036.
     PubMed     Abstract available
     
     
     
123. CENAT JM, Dromer E, Farahi SMMM, Ndamage CM, et al
     Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis.
     Thromb Res. 2024;238:197-205.
     PubMed     Abstract available
     
     
     
124. MITTA P, DiFatta J, Mahler C, Huang J, et al
     Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies.
     Thromb Res. 2024;239:109027.
     PubMed     Abstract available
     
     
     April 2024
125. JOHARIVARNOOSFADERANI N, Abedi SS
     A thromboembolic event as the first presentation of essential thrombocytosis: A case report.
     Thromb Res. 2024;238:103-104.
     PubMed    
     
     
     
126. DOGAN C, Samanci S
     The course of pulmonary embolism in individuals recovered from COVID-19.
     Thromb Res. 2024;238:232-234.
     PubMed    
     
     
     
127. DE JONG CMM, Kroft LJM, van Mens TE, Huisman MV, et al
     Modern imaging of acute pulmonary embolism.
     Thromb Res. 2024;238:105-116.
     PubMed     Abstract available
     
     
     
128. IKEDA S, Yamashita Y, Morimoto T, Chatani R, et al
     Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
     Thromb Res. 2024;238:27-36.
     PubMed     Abstract available
     
     
     
129. PALARETI G, Legnani C, Tosetto A, Poli D, et al
     D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
     Thromb Res. 2024;238:52-59.
     PubMed     Abstract available
     
     
     
130. MO M, Lian Z, Xiang Y, Du X, et al
     Association between perioperative red blood cell transfusions and postoperative venous thromboembolism: A systematic review and meta-analysis.
     Thromb Res. 2024;237:163-170.
     PubMed     Abstract available
     
     
     
131. LOPEZ N, Zamora-Martinez C, Montoya-Rodes M, Gabara C, et al
     Comparison of inferior vena cava filter use and outcomes between cancer and non-cancer patients in a tertiary hospital.
     Thromb Res. 2024;236:136-143.
     PubMed     Abstract available
     
     
     March 2024
132. MOKART D, Serre E, Bruneel F, Kouatchet A, et al
     Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study.
     Thromb Res. 2024;237:129-137.
     PubMed     Abstract available
     
     
     
133. GUTIERREZ-GUISADO J, Calvo-Sotelo AE, Hernandez-Blasco L, Fidalgo A, et al
     Venous thromboembolism (VTE) developing after ankle sprain. Comparison with VTE after knee arthroplasty.
     Thromb Res. 2024;237:94-99.
     PubMed     Abstract available
     
     
     
134. BAASTRUP NN, Buch AK, Gundestrup AK, Olsen ASF, et al
     The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery programme.
     Thromb Res. 2024;237:46-51.
     PubMed     Abstract available
     
     
     
135. LUTFI A, O'Rourke E, Crowley M, Craig E, et al
     VTE risk assessment, prevention and diagnosis in pregnancy.
     Thromb Res. 2024;235:164-174.
     PubMed     Abstract available
     
     
     February 2024
136. OGIHARA Y, Yamashita Y, Morimoto T, Chatani R, et al
     Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
     Thromb Res. 2024;236:191-200.
     PubMed     Abstract available
     
     
     
137. FLYNN C, Baldassarra J, Hamidi A
     Enoxaparin is safe for the treatment of venous thromboembolisms in patients with renal dysfunction: A retrospective cohort study.
     Thromb Res. 2024;236:127-129.
     PubMed    
     
     
     
138. RAJPURKAR M, Rosovsky RP, Williams S, Chan AKC, et al
     Considerations for instituting pediatric pulmonary embolism response teams: A tool kit.
     Thromb Res. 2024;236:97-107.
     PubMed     Abstract available
     
     
     
139. BHANGU G, Murray A, Qayyum A, Goumeniouk N, et al
     Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review.
     Thromb Res. 2024;236:108-116.
     PubMed     Abstract available
     
     
     
140. SIMARD C, Poirier-Blanchette L, Rizzolo A, Cafaro T, et al
     Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative.
     Thromb Res. 2024;236:68-73.
     PubMed     Abstract available
     
     
     
141. BAO L, Fang LJ, Xiao MY, Lu MQ, et al
     Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study.
     Thromb Res. 2024;236:130-135.
     PubMed     Abstract available
     
     
     
142. VAN OMMEN CH, Luijnenburg SE
     Anticoagulation of pediatric patients with venous thromboembolism in 2023.
     Thromb Res. 2024 Feb 10:S0049-3848(24)00032.
     PubMed     Abstract available
     
     
     January 2024
143. FAN Z, Xu S, Deng Y, Wei L, et al
     Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism.
     Thromb Res. 2024;235:68-74.
     PubMed     Abstract available
     
     
     
144. CHAIBI S, Roy PM, Guenegou AA, Tran Y, et al
     Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial.
     Thromb Res. 2024;235:79-87.
     PubMed     Abstract available
     
     
     
145. YOO J, Jeon J, Baik M, Kim J, et al
     Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study.
     Thromb Res. 2024;235:32-40.
     PubMed     Abstract available
     
     
     
146. CHOPARD R, Bertoletti L, Piazza G, Jimenez D, et al
     External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry.
     Thromb Res. 2024;235:22-31.
     PubMed     Abstract available
     
     
     
147. ABDULREHMAN J, Harrigan A, Simard C, Tagalakis V, et al
     TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.
     Thromb Res. 2024;235:11-14.
     PubMed    
     
     
     
148. ABRAHAO R, Brunson A, Chubak J, Wernli KJ, et al
     Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
     Thromb Res. 2024;235:1-7.
     PubMed     Abstract available
     
     
     
149. CASPERSEN CK, Ingemann-Molden S, Grove EL, Hojen AA, et al
     Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review.
     Thromb Res. 2024;235:52-67.
     PubMed     Abstract available
     
     
     
150. TIRATRAKOONSEREE T, Charoenpichitnun S, Natesirinilkul R, Songthawee N, et al
     Clinical prediction tool to identify children at risk of pulmonary embolism.
     Thromb Res. 2024;234:151-157.
     PubMed     Abstract available
     
     
     
151. HOUGHTON DE, Casanegra AI, Wysokinski WE, Padrnos LJ, et al
     COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds.
     Thromb Res. 2024;235:8-10.
     PubMed    
     
     
     
152. YAN AR, Samarawickrema I, Naunton M, Peterson GM, et al
     Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
     Thromb Res. 2024;234:120-133.
     PubMed     Abstract available
     
     
     
153. CHATANI R, Yamashita Y, Morimoto T, Mushiake K, et al
     Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
     Thromb Res. 2024;234:86-93.
     PubMed     Abstract available
     
     
     December 2023
154. OBRADOVIC S, Dzudovic B, Simpson T, Matijasevic J, et al
     S wave resolution in lead aVL at 48 hours after pulmonary embolism admission predicts lower mortality.
     Thromb Res. 2023;234:36-38.
     PubMed    
     
     
     
155. GUMAN NAM, Kaptein FHJ, Lohle SB, Mairuhu ATA, et al
     Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: A multicenter retrospective cohort study.
     Thromb Res. 2023;233:181-188.
     PubMed     Abstract available
     
     
     
156. PUCHADES R, Tung-Chen Y, Salgueiro G, Lorenzo A, et al
     Artificial intelligence for predicting pulmonary embolism: A review of machine learning approaches and performance evaluation.
     Thromb Res. 2023;234:9-11.
     PubMed    
     
     
     
157. RUEDA-CAMINO JA, Barba R, Otalora S, Bura-Riviere A, et al
     Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism.
     Thromb Res. 2023;233:165-172.
     PubMed     Abstract available
     
     
     
158. FRENZEL L, Decaux O, Macro M, Belhadj-Merzoug K, et al
     Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
     Thromb Res. 2023;233:153-164.
     PubMed     Abstract available
     
     
     
159. TRITSCHLER T, Sadeghipour P, Bikdeli B
     Subgroup analysis in randomized controlled trials: Useful or misleading?
     Thromb Res. 2023;232:160-162.
     PubMed    
     
     
     November 2023
160. LIPPI G, Mattiuzzi C, Favaloro EJ
     Recent monthly mortality for pulmonary embolism in the US.
     Thromb Res. 2023;233:99-100.
     PubMed    
     
     
     
161. INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
     Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
     Thromb Res. 2023;233:69-81.
     PubMed     Abstract available
     
     
     
162. NAJARRO M, Briceno W, Rodriguez C, Muriel A, et al
     Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism.
     Thromb Res. 2023;233:18-24.
     PubMed     Abstract available
     
     
     
163. APARICIO I, Iranzo P, Reyes R, Bote H, et al
     Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
     Thromb Res. 2023;232:133-137.
     PubMed     Abstract available
     
     
     
164. CHEN AC, Rao AS, Oropallo A, Goldhaber SZ, et al
     Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
     Thromb Res. 2023;232:123-132.
     PubMed     Abstract available
     
     
     
165. HEERINK JS, Oudega R, Gemen E, Hopstaken R, et al
     Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism.
     Thromb Res. 2023;232:113-122.
     PubMed     Abstract available
     
     
     
166. ZABCZYK M, Kruk A, Natorska J, Undas A, et al
     Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
     Thromb Res. 2023;232:70-76.
     PubMed     Abstract available
     
     
     
167. BIKDELI B, Piazza G
     The CORONA-VTE network registry: Revisiting the realities while encouraging enthusiasm.
     Thromb Res. 2023;231:7.
     PubMed    
     
     
     October 2023
168. PAREDES D, Del Carmen Diaz-Pedroche M, Gomez-Cuervo C, Perez-Jacoiste A, et al
     Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism.
     Thromb Res. 2023;232:54-61.
     PubMed     Abstract available
     
     
     
169. KAPTEIJN MY, Lanting VR, Kaptein FHJ, Guman NAM, et al
     RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
     Thromb Res. 2023;232:27-34.
     PubMed     Abstract available
     
     
     
170. TSUJISAKA Y, Yamashita Y, Morimoto T, Takase T, et al
     Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
     Thromb Res. 2023;232:35-42.
     PubMed     Abstract available
     
     
     
171. ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
     Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
     Thromb Res. 2023;231:91-98.
     PubMed     Abstract available
     
     
     
172. YHIM HY, Lee J, Kim KH, Kim SA, et al
     Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
     Thromb Res. 2023;231:50-57.
     PubMed     Abstract available
     
     
     September 2023
173. MAVROMANOLI AC, Jimenez D, Sanchez O, Sobkowicz B, et al
     Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
     Thromb Res. 2023;231:29-31.
     PubMed    
     
     
     
174. RAMBAUD G, Mai V, Motreff C, Sanchez O, et al
     Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
     Thromb Res. 2023;231:58-64.
     PubMed     Abstract available
     
     
     
175. XU Y, Khan F, Kovacs MJ, Sabri E, et al
     Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
     Thromb Res. 2023;231:32-38.
     PubMed     Abstract available
     
     
     
176. DRAGSBAEK SJ, Lyhne MD, Hansen JV, Pedersen CCE, et al
     A porcine model of human-like chronic thromboembolic pulmonary disease.
     Thromb Res. 2023;231:25-28.
     PubMed    
     
     
     
177. STALS MAM, Beenen LFM, Coppens M, Faber LM, et al
     Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
     Thromb Res. 2023;231:65-75.
     PubMed     Abstract available
     
     
     
178. AVERY J, Guffey D, Ma S, Basom R, et al
     Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.
     Thromb Res. 2023;229:1-6.
     PubMed     Abstract available
     
     
     August 2023
179. CHU G, Seelig J, Cannegieter SC, Gelderblom H, et al
     Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
     Thromb Res. 2023;230:98-104.
     PubMed     Abstract available
     
     
     
180. SCOTT DM, Abud A, Amor M, Saemi A, et al
     Natural Language Processing tool accurately identifies acute venous thromboembolism.
     Thromb Res. 2023;229:252-254.
     PubMed    
     
     
     
181. FELIX G, Ferreira E, Ribeiro A, Guerreiro I, et al
     Predictors of cancer in patients with acute pulmonary embolism.
     Thromb Res. 2023;230:11-17.
     PubMed     Abstract available
     
     
     July 2023
182. MEYER HJ, Gottschling S, Bar C, Wienke A, et al
     CT coronary calcium score is a prognostic marker in acute pulmonary embolism.
     Thromb Res. 2023;229:255-257.
     PubMed    
     
     
     
183. BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
     Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
     Thromb Res. 2023;229:139-145.
     PubMed     Abstract available
     
     
     
184. ANIJS RJS, Chen Q, van der Hulle T, Versteeg HH, et al
     Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
     Thromb Res. 2023;229:90-98.
     PubMed     Abstract available
     
     
     
185. ALMAJDI A, Almutairi S, Alharbi M
     Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis.
     Thromb Res. 2023;229:77-85.
     PubMed     Abstract available
     
     
     
186. HYDER SN, Han HB, Ash S, Horne BD, et al
     Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
     Thromb Res. 2023;227:45-50.
     PubMed     Abstract available
     
     
     June 2023
187. LOWE G, Wu O, van Hylckama Vlieg A, Folsom A, et al
     Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.
     Thromb Res. 2023;229:31-39.
     PubMed     Abstract available
     
     
     
188. FILIPPI L, Turcato G, Milan M, Barbar S, et al
     Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.
     Thromb Res. 2023;229:73-76.
     PubMed     Abstract available
     
     
     
189. JERVAN O, Dhayyat A, Gleditsch J, Haukeland-Parker S, et al
     Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism.
     Thromb Res. 2023;229:7-14.
     PubMed     Abstract available
     
     
     
190. MUNOZ AJ, Souto JC, Lecumberri R, Obispo B, et al
     Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
     Thromb Res. 2023;228:181-188.
     PubMed     Abstract available
     
     
     
191. JAOUEN S, Mingant F, Lippert E, Galinat H, et al
     Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
     Thromb Res. 2023;228:191-199.
     PubMed     Abstract available
     
     
     
192. ZUIN M, Bikdeli B, Davies J, Krishnathasan D, et al
     Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019.
     Thromb Res. 2023;228:72-80.
     PubMed     Abstract available
     
     
     
193. BROWN C, Brandt W, Wang TF, Delluc A, et al
     Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
     Thromb Res. 2023;228:81-84.
     PubMed     Abstract available
     
     
     May 2023
194. OTERO R, Lobo JL, Lopez R, Fernandez C, et al
     Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
     Thromb Res. 2023;228:1-9.
     PubMed     Abstract available
     
     
     
195. ADDA-REZIG I, Cossu J, Falvo N, Ecarnot F, et al
     Home treatment versus early discharge for the outpatient management of acute pulmonary embolism: A non-interventional, post-hoc cohort analysis.
     Thromb Res. 2023;227:25-33.
     PubMed     Abstract available
     
     
     
196. PALLARES ROBLES A, Ten Cate V, Lenz M, Schulz A, et al
     Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification.
     Thromb Res. 2023 May 8:S0049-3848(23)00124.
     PubMed     Abstract available
     
     
     April 2023
197. LI HY, Wang J, Wang T, Wang HS, et al
     Management of venous thromboembolism in pediatric patients: Quality assessment of clinical practice guidelines and variations in recommendations.
     Thromb Res. 2023;226:107-116.
     PubMed     Abstract available
     
     
     
198. CHIU J, Lazo-Langner A
     Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review.
     Thromb Res. 2023;226:141-149.
     PubMed     Abstract available
     
     
     
199. DROPPA M, Zdanyte M, Henes JK, Gawaz M, et al
     Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis.
     Thromb Res. 2023;226:33-35.
     PubMed    
     
     
     
200. KAPTEIN FHJ, Kroft LJM, van Dam LF, Stoger JL, et al
     Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes.
     Thromb Res. 2023;226:51-55.
     PubMed     Abstract available
     
     
     
201. KELLER K, Kohring C, Farmakis IT, Valerio L, et al
     Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
     Thromb Res. 2023;226:9-17.
     PubMed     Abstract available
     
     
     
202. QIAO N, Zhang Q, Chen L, He W, et al
     Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
     Thromb Res. 2023;226:1-8.
     PubMed     Abstract available
     
     
     
203. COHEN A, Noxon V, Dhamane A, Bruette R, et al
     Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
     Thromb Res. 2023;226:117-126.
     PubMed     Abstract available
     
     
     March 2023
204. ZBINDEN S, Voci D, Grigorean A, Holy EW, et al
     Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism.
     Thromb Res. 2023;225:73-78.
     PubMed     Abstract available
     
     
     
205. MATUSOV Y, Yaqoob M, Karumanchi A, Lipshutz HG, et al
     Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
     Thromb Res. 2023;225:57-62.
     PubMed     Abstract available
     
     
     
206. KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
     Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
     Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
     PubMed    
     
     
     
207. ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
     Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
     Thromb Res. 2023;225:28-32.
     PubMed     Abstract available
     
     
     February 2023
208. WIKLUND P, Medson K, Elf J
     Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
     Thromb Res. 2023;224:65-72.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum